Procter & Gamble Hygiene and Health Care Ltd. today announced its financial results for the fiscal and quarter ended June 30, 2022. Despite unprecedented headwinds from macroeconomic challenges and softening consumption trends, the Company continued to grow and delivered a resilient performance in the fiscal with sales of ₹3,901 crore, up 9% versus year ago, behind the proven superiority strategy and strong brand fundamentals. Profit After Tax (PAT) was ₹576 crore, down 12% versus year ago, largely behind commodities inflation which was significantly countered by cost productivity and pricing in the current year. Compared to the fiscal two years ago, the Company's sales are up 30% and Profit After Tax (PAT) is up 33%.
For the quarter ended June 30, 2022, the company delivered sales of ₹776 crore, down 1% versus year ago. Profit After Tax (PAT) was ₹43 crore, down 13% versus year ago largely behind commodity cost inflation. For the quarter, both feminine care and healthcare businesses continue to grow and maintain category leadership.
LV Vaidyanathan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. said, "The operating environment continues to be marked by unprecedented headwinds and commodity fluctuations. Despite these challenges, we remain resilient, agile, and committed to serve Indian consumers, delivering sequential sales growth this year. The execution of our integrated strategies of a strong portfolio, superiority, productivity, constructive disruption, and an agile and accountable organization structure, has empowered us to deliver these consistent results. Our strategy is fueled by balancing innovation and industry-leading practices, while driving productivity in everything we do." He further added, "While the unprecedented market challenges and uncertainties remain in the near-term, we will continue to stay focused on our strategy of driving superiority and productivity and enabled by the strength of our organization and culture, to deliver balanced growth and value creation."
Our feminine care and healthcare brands, Whisper and Vicks, continue to grow behind a strong product portfolio, superior consumer communication and a continuous stream of product innovations like Whisper Choice Nights, Vicks Roll-On Inhaler, Vicks Xtra Strong and Vicks Tulsi Ginger Cough Syrup.
The Company continues to aspire to create positive impact across each area of Citizenship-Community Impact, Equality & Inclusion, and Environmental Sustainability. Through its flagship CSR program, P&G Shiksha, the P&G group in India has supported over 2500 schools that will impact more than 23 lakh children. Over the years, P&G Shiksha has evolved into a 360-degree educational intervention addressing three critical barriers to achieving universal education - access to education infrastructure, gender inequality in access to education and gap in learning.
The directors have recommended a final dividend of ₹ 65 per Equity Share for the Financial Year ended June 30, 2022, subject to the approval of Shareholders of the company at the ensuing 58th Annual General Meeting.
Shares of Procter & Gamble Hygiene and Health Care Limited was last trading in BSE at Rs. 14392.50 as compared to the previous close of Rs. 14597.50. The total number of shares traded during the day was 605 in over 331 trades.
The stock hit an intraday high of Rs. 14736.55 and intraday low of 14302.10. The net turnover during the day was Rs. 8781583.00.